APA (7th ed.) Citation

CL, H., BW, T., LJ, Y., ZN, D., H, L., XC, M., . . . T, L. (2023). Efficacy and safety of immune checkpoint inhibitors for hepatocellular carcinoma patients with macrovascular invasion or extrahepatic spread: A systematic review and meta-analysis of 54 studies with 6187 hepatocellular carcinoma patients. Cancer immunology, immunotherapy : CII, 72(7), 1957. https://doi.org/10.1007/s00262-023-03390-x

Chicago Style (17th ed.) Citation

CL, Han, et al. "Efficacy and Safety of Immune Checkpoint Inhibitors for Hepatocellular Carcinoma Patients with Macrovascular Invasion or Extrahepatic Spread: A Systematic Review and Meta-analysis of 54 Studies with 6187 Hepatocellular Carcinoma Patients." Cancer Immunology, Immunotherapy : CII 72, no. 7 (2023): 1957. https://doi.org/10.1007/s00262-023-03390-x.

MLA (9th ed.) Citation

CL, Han, et al. "Efficacy and Safety of Immune Checkpoint Inhibitors for Hepatocellular Carcinoma Patients with Macrovascular Invasion or Extrahepatic Spread: A Systematic Review and Meta-analysis of 54 Studies with 6187 Hepatocellular Carcinoma Patients." Cancer Immunology, Immunotherapy : CII, vol. 72, no. 7, 2023, p. 1957, https://doi.org/10.1007/s00262-023-03390-x.